NYXH · NYXOAH S A

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Medical Devices
Healthcare

Market Cap

89.63M

52 Wk Range

$0.80 - $5.92

Previous Close

$0.88

Open

$0.88

Volume

173,077

Day Range

$0.86 - $0.91

Enterprise Value

39.4M

Cash

97.79M

Avg Qtr Burn

-16.57M

Insider Ownership

33.19%

Institutional Own.

31.02%

Qtr Updated

Jun 30th 2026